Associations between virologic and immunologic dynamics in blood and in the male genital tract

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1307-1315

  Gianella, Sara ^a   Strain, Matthew C ^a   Rought, Steffney E ^b   Vargas, Milenka V ^a   Little, Susan J ^a   Richman, Douglas D ^a,c   Spina, Celsa A ^a,c   Smith, Davey M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPONENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MALE GENITAL TRACT INFECTION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEMEN ANALYSIS; T LYMPHOCYTE;

ANTIGENS, CD; BASE SEQUENCE; CYTOMEGALOVIRUS; DNA PRIMERS; FLOW CYTOMETRY; GENITALIA, MALE; HIV; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SEMEN;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

EID: 84863176906     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06077-11     Document Type: Article

References (83)

1. Almanzar G, et al. 2005. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8_ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79:3675-3683.
2. Althaus CF, Gianella S, et al. 2010. Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance. J. Virol. Methods 165:151-160.
3. Anderson BL, et al. 2008. Genital tract leukocytes and shedding of genital HIV type 1 RNA. Clin. Infect. Dis. 47:1216 -1221.
4. Anderson DJ, et al. 1992. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 267:2769 -2774.
5. Anderson DJ, et al. 2010. Targeting Trojan Horse leukocytes for HIV prevention. AIDS 24:163-187.
6. Anderson JA, et al. 2010. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 6:e1001053.
7. Baeten JM, et al. 2011.Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci. Transl. Med.
8. Baeten JM, et al. 2004. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial. J. Infect. Dis. 189:1466 -1471.
9. Barratt CL, Harrison PE, Robinson A, Kessopoulou E, Cooke ID. 1991. Seminal white blood cells in men with urethral tract infection. A monoclonal antibody study. Br. J. Urol. 68:531-536.
10. Brenchley JM, et al. 2004. CD4_T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749 -759.
11. Bresson JL, et al. 2003. Risk of cytomegalovirus transmission by cryopreserved semen: a study of 635 semen samples from 231 donors. Hum. Reprod. 18:1881-1886.
12. Butler DM, et al. 2010.The origins of sexually transmitted HIV among men who have sex with men. Sci. Transl. Med.
13. Butler DM, et al. 2008. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 22:1667-1671.
14. Celum C, et al. 2010. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N. Engl. J. Med. 362:427- 439.
15. Cohen MS, et al. 1997. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349: 1868-1873.
16. Dalgleish AG, et al. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
17. Davis MG, Kenney SC, Kamine J, Pagano JS, Huang ES. 1987. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 84:8642- 8646.
18. Deayton JR, et al. 2004. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363:2116 -2121.
19. Denny TN, et al. 1995. Evaluation of T-lymphocyte subsets present in semen and peripheral blood of healthy donors: a report from the heterosexual transmission study. Cytometry 20:349 -355.
20. Detels R, et al. 1994. Persistent cytomegalovirus infection of semen increases risk of AIDS. J. Infect. Dis. 169:766 -768.
21. Detels R, et al. 1987. Predictors of clinical AIDS in young homosexual men in a high-risk area. Int. J. Epidemiol. 16:271-276.
22. Diamond C, et al. 2000. Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men. J. Virol. Methods 90: 185-191.
23. Effros RB, et al. 2008. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin. Infect. Dis. 47:542-553.
24. El Amari EB, et al. 2011. Clinical relevance of cytomegalovirus viraemia. HIV Med. 12:394-402.
25. Emery VC, et al. 1999. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J. Infect. Dis. 180: 695-701.
26. Fauci AS. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617- 622.
27. Fiebig EW, et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
28. Galvin SR, Cohen MS. 2004. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2:33- 42.
29. Gandhi RT, et al. 2006. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J. Acquir. Immune Defic. Syndr. 42:426-434.
30. Gartner S, et al. 1986. The role of mononuclear phagocytes in HTLV-III/ LAV infection. Science 233:215-219.
31. Gray RH, et al. 2001. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149 -1153.
32. Haas A, et al. 2010. HIV-1 replication activates CD4_ T cells with specificities for persistent herpes viruses. EMBO Mol. Med. 2:231-244.
33. Hadrup SR, et al. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176:2645-2653.
34. Hecht FM, et al. 2006. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J. Infect. Dis. 194:725-733.
35. Hunt PW, et al. 2003. T cell activation is associated with lower CD4_ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187: 1534-1543.
36. Hunt PW, et al. 2011. Valganciclovir reduces T cell activation in HIVinfected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J. Infect. Dis. 203:1474 -1483.
37. Jabs DA, et al. 2005. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 112:771-779.
38. Johnson LF, Lewis DA. 2008. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex. Transm. Dis. 35:946-959.
39. Kalichman SC, Di Berto G, Eaton L. 2008. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex. Transm. Dis. 35:55-60.
40. Kaul R, et al. 2008. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J. Reprod. Immunol. 77:32- 40.
41. Killian MS, et al. 2004. Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men. AIDS 18:161-170.
42. Kosakovsky Pond SL, et al. 2009. An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput. Biol. 5:e1000581.
43. Krieger JN, et al. 1995. Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls. J. Infect. Dis. 171:1018-1022.
44. Laga M, et al. 1993. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95-102.
45. Lang DJ, Kummer JF. 1972. Demonstration of cytomegalovirus in semen. N. Engl. J. Med. 287:756-758.
46. Lange M, Klein EB, Kornfield H, Cooper LZ, Grieco MH. 1984. Cytomegalovirus isolation from healthy homosexual men. JAMA 252: 1908-1910.
47. Leach CT, et al. 1993. The relationship between T-cell levels and CMV infection in asymptomatic HIV-1 antibody-positive homosexual men. J. Acquir. Immune Defic. Syndr. 6:407-413.
48. Lenkei R, Andersson B. 1995. High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors. Clin. Immunol. Immunopathol. 77:131-138.
49. Limaye AP, et al. 2008. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300:413- 422.
50. Lingappa JR, et al. 2010. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 375:824-833.
51. Little SJ, et al. 2008. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J. Virol. 82:5510 -5518.
52. Lomas DA, Natin D, Stockley RA, Shahmanesh M. 1993. Chemotactic activity of urethral secretions in men with urethritis and the effect of treatment. J. Infect. Dis. 167:233-236.
53. Mbopi-Keou FX, et al. 2000. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J. Infect. Dis. 182:1090 -1096.
54. Mehandru S, et al. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770.
55. Ouyang Q, et al. 2003. Large numbers of dysfunctional CD8+T lymphocytes bearing receptors for a single dominantCMVepitope in the very old. J. Clin. Immunol. 23:247-257.
56. Pinto-Neto LF, et al. 2002. Lack of correlation between seminal and plasma HIV-1 viral loads is associated with CD4 T cell depletion in therapy-naive HIV-1+ patients. Mem. Inst. Oswaldo Cruz 97:563-567.
57. Politch JA, Mayer KH, Anderson DJ. 2009. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 50:283-289.
58. Polk BF, et al. 1987. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N. Engl. J. Med. 316:61-66.
59. Quinn TC, et al. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342:921.
60. Rinaldo CR, Jr, Kingsley LA, Ho M, Armstrong JA, Zhou SY. 1992. Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J. Clin. Microbiol. 30: 1148-1155.
61. Rottingen JA, Cameron DW, Garnett GP. 2001. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex. Transm. Dis. 28:579 -597.
62. Royce RA, Sena A, Cates W, Cohen MS. 1997. Sexual transmission of HIV. N. Engl. J. Med. 336:1072.
63. Sauce D, et al. 2009. Evidence of premature immune aging in patients thymectomized during early childhood. J. Clin. Invest. 119:3070 -3078.
64. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. 2002. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis. 186: 1718-1725.
65. Sheth PM, et al. 2005. HIV-specific CD8R lymphocytes in semen are not associated with reduced HIV shedding. J. Immunol. 175:4789-4796.
66. Sheth PM, et al. 2006. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J. Infect. Dis. 193:45- 48.
67. Skolnik PR, Kosloff BR, Hirsch MS. 1988. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J. Infect. Dis. 157:508 -514.
68. Smith DM, et al. 2004. The prostate as a reservoir for HIV-1. AIDS 18:1600.
69. Speck CE, et al. 1999. Risk factors for HIV-1 shedding in semen. Am. J. Epidemiol. 150:622-631.
70. Spector SA, Wong R, Hsia K, Pilcher M, Stempien MJ. 1998. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest. 101:497-502.
71. Sylwester AW, et al. 2005. Broadly targeted human cytomegalovirusspecific CD4_and CD8_T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
72. Vernazza PL, et al. 1997. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 11:987.
73. Vescovini R, et al. 2010. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J. Immunol. 184:3242-3249.
74. Wawer MJ, et al. 2005. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191:1403-1409.
75. Webster A, et al. 1989. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet ii:63- 66.
76. Weiss, H. 2004. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11(Suppl 1):24A-35A.
77. Wikby A, et al. 2002. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37: 445-453.
78. Wilcoxon F. 1945. Individual comparisons by ranking methods. Biometrics Bull. 1:80-83.
79. Wolff H, Anderson DJ. 1988. Male genital tract inflammation associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia 20:404-410.
80. Xu C, et al. 1997. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J. Infect. Dis. 176: 941-947.
81. Yang OO, et al. 2002. Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Res. Hum. Retroviruses 18:1051-1065.
82. Yen-Lieberman B, et al. 1996. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J. Clin. Microbiol. 34:2695-2701.
83. Zagury D, et al. 1986. Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231: 850-853.